Transferability of trial results to health care

2. Discussion forum on assessing benefit in health care organized by the German health research council [Gesundheitsforschungsrat (GFR)] and IQWiG on 21 October 2008 in Berlin.

I. Introduction to the problem

Main issues: Can trial results be transferred to clinical routine? What factors influence the transfer? If the trial results are not transferred, what effect does this have on clinical routine?

	Implementing trial results in clinical practice - using cardiology as an example: drug-eluting stents (German) download slides Prof. Dr. Rutsch HELIOS Klinikum, Berlin wolfgang.rutsch(AT)helios-kliniken.de
	Transferring trial results into daily practice Obstacles, old and new trials (German) download slides Prof. Dr. med. Johannes Forster St. Josefskrankenhaus, Freiburg Johannes.Forster(AT)rkk-sjk.de
	Can trial results from pharmacological interventions be transferred into daily practice? (German) download slides Prof. Dr. med. Petra A. Thürmann HELIOS Klinikum Wuppertal www.helios-kliniken.de/wuppertal
	Transferring trial results to health care Non-pharmacological interventions (surgery) (German) download slides Prof. Dr. H. Bauer German Society for Surgery, Berlin H.Bauer(AT)dgch.de

II. Approaches to a solution

Main issue: How can we close the gap between trial results and their transfer to routine health care?

Transfer of health care results to everyday care - Various qualitative and quantitative research approaches (German)

download slides

Prof. Dr. Karl Wegscheider
University Hospital Hamburg-Eppendorf
Institut für Medizinische Biometrie und Epidemiologie
k.wegscheider(AT)uke.de

GRADE System: from evidence to recommendation. Description of the system and proposal for transferability of trial results (German)

download slides

Prof. Dr. Holger Schünemann
Italian National Cancer Institute "Regina Elena", Rome
schuneh(AT)mcmaster.ca

Pragmatic trials within the setting of routine health care as a proposed solution (German)

download slides

Prof. Dr. Norbert Donner-Banzhoff
Marburg University, Department for General Medicine, Preventive and Rehabilitation Medicine
donnerba(AT)med.uni-marburg.de

III. How benefit assessments and decisions are affected (discussion)

Main issues: What action should be taken in assessing benefit in health care when the external validity of trial results has received a negative assessment? If there is no transfer, does this have an impact on decisions in the health care system (Federal Joint Committee, G-BA)?

Introductory statement to discussion (German)

download slides

PD Dr. med. Matthias Perleth, MPH
Federal Joint Committee,
Department for Medical Affairs
matthias.perleth(AT)g-ba.de

Go to the GFR website for further information on the first joint discussion forum held by GFR and IQWiG on assessing benefit in the German health care system.

Booklet on the first discussion forum 'Definitions of the term benefit'